Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels
Open Access
- 1 April 1983
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 24 (4) , 461-468
- https://doi.org/10.1016/s0022-2275(20)37987-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acidEuropean Journal of Clinical Investigation, 1981
- Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids*European Journal of Clinical Investigation, 1980
- The rediscovery of high density lipoprotein: a negative risk factor in atherosclerosisEuropean Journal of Clinical Investigation, 1978
- The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.Journal of Clinical Investigation, 1978
- Chenotherapy for Gallstone DissolutionPublished by American Medical Association (AMA) ,1978
- Enzymatic determination of cholesterol in bileClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Effect of Oral Chenodeoxycholic Acid on Bile Acid Kinetics and Biliary Lipid Composition in Women with CholelithiasisJournal of Clinical Investigation, 1973
- Lipoprotein fractionation.Journal of Clinical Pathology, 1973
- Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spotsLipids, 1970
- Determination of Small Amounts of Total Cholesterol by the Tschugaeff Reaction with a Note on the Determination of Lathosterol.Acta Chemica Scandinavica, 1955